U.S. Lawmakers Probe Merck, AbbVie Over China Clinical Trials

US House Committee Probes Big Pharma Over China Clinical Trials

The committee cited concerns about national security, data protection, intellectual property, and research ethics, particularly involving military hospitals and institutions in China's Xinjiang region

U.S. Lawmakers Probe Merck, AbbVie Over China Clinical Trials

A bipartisan group of U.S. lawmakers has launched national security investigations into whether pharmaceutical companies Merck and AbbVie participated in clinical trials in China that may have contributed to the country's military capabilities.